New prescriptions for puberty blockers were to be banned by the Government just before Christmas, but an urgent High Court injunction has called a halt to the new regulations and a judicial review is set down for May.
The findings of an independent report and subsequent major clinical trial in the UK prompted the Health Minister Simeon Brown to press pause on the medications for new patients with gender dysphoria.
The four-year Cass Review, carried out for NHS England recommends limiting the use of puberty blockers to research settings. It also urges unhurried holistic care, caution around irreversible treatments, and the recognition of complex factors such as mental health, neurodiversity and social media as possible contributors to the rise in young people questioning their gender.
Report author Baroness Dr Hilary Cass is a paediatrician and former president of the Royal College of Paediatrics and Child Health in the UK. She joins Susie live from the UK.
Photo: Roger Harris - UK Parliament 2026
